Dexmedetomidine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dexmedetomidine Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Dexmedetomidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 19 USDMF, 5 JDMF, 5 EU WC, 13 KDMF, 16 NDC API, 8 VMF, 33 Listed Suppliers, $ API Reference Price

49 API Suppliers
19 USDMF
5 JDMF
5 EU WC
13 KDMF
16 NDC API
8 VMF
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

42 Drugs in Development

42 Drugs in Development

FINISHED DOSAGE FORMULATIONS

97 FDF Dossiers, 60 FDA Orange Book, 6 Europe, 17 Canada, 3 South Africa, 11 Listed Dossiers

97 FDF Dossiers
60 FDA Orange Book
6 Europe
17 Canada
3 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)
INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)
INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis

2 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 54 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
54 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices, 4 Annual Reports

4 Finished Drug Prices
4 Annual Reports

MARKET PLACE

21 APIs, 8 FDF Dossiers

21 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

70 US Patents, 9 US Exclusivities, 3 Health Canada Patents

70 US Patents
9 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 892,458 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Hospira Healthcare Corporation

02 1Pfizer Canada Inc.

03 1Pfizer Canada Inc., Pfizer Animal Health

filter Patent Reset all filters

3 All

01 21337659

02 12326339

filter Product Reset all filters

3 All

01 3Dexmedetomidine Hydrochloride

filter Dosage Reset all filters

3 All

01 2Solution

02 1Sterile injectable solution

filter Exp Date Reset all filters

3 All

01 22012-11-28

02 12019-03-31

Fermion Dexmedetomidine HCl

Product Main Page

01

Pfizer Canada Inc.

Dexmedetomidine Hydrochloride

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-03-31

Date Granted : 2008-12-23

Dexmedetomidine Hydrochloride

Brand Name : PRECEDEX

Patent Number : 2326339

Filing Date : 1999-03-31

Strength per Unit : 100 mcg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2019-03-31

Date Granted : 2008-12-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Hospira Healthcare Corporation

Dexmedetomidine Hydrochloride

BioAsia

Not Confirmed

Hospira Healthcare Corporation

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-11-28

Date Granted : 1995-11-28

Dexmedetomidine Hydrochloride

Brand Name : PRECEDEX

Patent Number : 1337659

Filing Date : 1988-07-14

Strength per Unit : 100 mcg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2012-11-28

Date Granted : 1995-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pfizer Canada Inc., Pfizer Animal Health

Dexmedetomidine Hydrochloride

BioAsia

Not Confirmed

Pfizer Canada Inc., Pfizer Animal H...

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-11-28

Date Granted : 1995-11-28

Dexmedetomidine Hydrochloride

Brand Name : DEXDOMITOR

Patent Number : 1337659

Filing Date : 1988-07-14

Strength per Unit : 0.5 mg / mL

Dosage Form : Sterile injectable solution

Human Or VET : Veterinary

Route of Administration : im - dogs, cats, iv - dogs

Patent Expiration Date : 2012-11-28

Date Granted : 1995-11-28

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!